Sale of shares in BioGaia AB

Published on Jun 24, 2019 at 11:00 CET

BioGaia has been informed by Annwall & Rothschild Investments AB (A & R AB), main shareholders in BioGaia, that they...

Interview with CEO Isabelle Ducellier in Dagens Industri

Published on May 17, 2019 at 15:18 CET

BioGaia’s CEO Isabelle Dueller has been interviewed by the Swedish financial newspaper Dagens Industri. Click at the following...

Published on May 09, 2019 at 08:00 CET

The Annual General Meeting of BioGaia AB (publ) on 8 May 2019 voted, among other things, to approve the following...

Published on May 08, 2019 at 08:00 CET

Comments from the CEO: Sales during the first quarter increased by 9% (excluding foreign exchange effects, 2%) compared to the...

Published on May 06, 2019 at 13:00 CET

A randomized, double-blind, placebo-controlled study with BioGaia’s probiotic strain Lactobacillus reuteri ATCC PTA 4659 was shown to...

Published on May 03, 2019 at 08:00 CET

The USA will be the first market to launch BioGaia’s new product for bone health, BioGaia Osfortis. The product...

Published on Apr 11, 2019 at 09:37 CET

BioGaia Gastrus is now available in Mongolia through our distribution partner Monospharm Trade MN. BioGaia Gastrus is a food supplement...

Published on Apr 11, 2019 at 09:15 CET

BioGaia Gastrus and BioGaia Prodentis is now available in Latin America. BioGaia Gastrus is available in Honduras and El Salvador...

Published on Apr 05, 2019 at 10:00 CET

BioGaia AB (publ) will hold its Annual General Meeting at 4:00 p.m. on Wednesday, 8 May 2019, at...